Aaron Scott, M.D.

(877) 460-4673
Aaron Scott, M.D.
Surgical Oncologist
Clinical Expertise
  • Surgical Oncology
Academic Appointments
  • Assistant Clinical Professor, Division of Surgical Oncology, Department of Surgery

Aaron Scott, M.D., is an assistant clinical professor of surgical oncology at City of Hope® Antelope Valley, where he brings his expertise as a cancer surgeon to patients across Southern California. Dr. Scott’s philosophy is to meet patients where they are, recognizing their individual hopes and health goals, and to treat them with compassion and clinical excellence.

Dr. Scott majored in physics as an undergraduate but chose to pivot to the field of medicine because it meant working directly with patients to improve their lives in a meaningful way. He earned his medical degree at Indiana University School of Medicine in Indianapolis, then completed a residency in general surgery at the University of Iowa Hospitals and Clinics in Iowa City (where he was also administrative chief resident), followed by a general surgical oncology fellowship at City of Hope.

His research, which has been published in more than a dozen peer-reviewed journals, focuses on topics including neuroendocrine tumors of the pancreas and liver and the use of biomarkers to manage small bowel tumors.

Location

Education & Experience

Degrees

  • 2015, Doctor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
  • 2011, Bachelor of Science, Physics & Psychology, Indiana University, Bloomington, Indiana
  • 2011, Bachelor of Arts, Mathematics, Indiana University, Bloomington, Indiana

Fellowship

  • 2024, Fellowship, Complex General Surgical Oncology, City of Hope, Duarte, California

Residency

  • 2022, Residency & Administrative Chief Resident, General Surgery, University of Iowa, Iowa City, Iowa

Professional Experience

  • 2024-present, Assistant Clinical Professor, Division of Surgical Oncology, Department of Surgery, City of Hope, Antelope Valley, California

Awards & Memberships

Awards

  • Best Basic Science Presentation, 1st place, resident research day 2019, Awarded for “Gene expression changes and potential new therapies for metastatic pancreatic neuroendocrine tumors” presented at annual, department wide presentation of resident and fellow research projects.
  • Best Clinical Presentation, 3rd place, resident research day 2018, Awarded for “Effective Cytoreduction can be Achieved in Patients with Numerous Neuroendocrine Tumor Liver Metastases.”
  • Best Basic Science Presentation, 3rd place, resident research day 2018, Awarded for “The Impact of Intra-Operative Bacterial Contamination on Peritoneal Recurrence of Pancreatic Cancer."

Publications

  • Scott A, Wong P, Melstrom LG. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma. Surgery. 2023 Jul;174(1):113-115.
  • Catherine G Tran, Scott K Sherman, Aaron T Scott, Po Hien Ear, Chandrikha Chandrasekharan, Andrew M Bellizzi, Joseph S Dillon, Thomas M O'Dorisio, James R Howe. It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors. Ann Surg Oncol. 2020 Jul 11.
  • Catherine G Tran, Aaron T Scott, Guiying Li, Scott K Sherman, Po Hien Ear, James R Howe. Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling. Surgery. 2020 Jun 28;S0039-6060(20)30243-9.
  • Aaron Scott, Paolo Goffredo, Timothy Ginader, Jennifer Hrabe , Irena Gribovskaja-Rupp, Muneera R Kapadia, Ronald J Weigel, Imran Hassan. The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database. J Gastrointest Surg. 2020 Jun;24(6):1402-1410.
  • Aaron T Scott and James R Howe. Management of Small Bowel Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr;29(2):223-241.
  • Aaron T Scott, Michelle Weitz, Patrick J Breheny, Po Hien Ear, Benjamin Darbro, Bart J Brown, Terry A Braun, Guiying Li, Shaikamjad Umesalma, Courtney A Kaemmer, Chandra K Maharjan, Dawn E Quelle, Andrew M Bellizzi, Chandrikha Chandrasekharan, Joseph S Dillon, Thomas M O'Dorisio, James R Howe. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clin Cancer Res. 2020 Apr 15;26(8):2011-2021.
  • Aaron T Scott and James R Howe. Evaluation and Management of Neuroendocrine Tumors of the Pancreas. Surg Clin North Am. 2019 Aug;99(4):793-814.
  • Aaron T Scott, Daniel Pelletier, Jessica E Maxwell, Scott K Sherman, Kendall J Keck, Guiying Li, Joseph S Dillon, Thomas M O'Dorisio, Andrew M Bellizzi, James R Howe. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors. Ann Surg Oncol. 2019 Aug;26(8):2525-2532.
  • Goffredo P, Robinson TJ, Frakes JM, Utria AF, Scott AT, Hassan I. Comparison of Anal Versus Rectal Staging in the Prognostication of Rectal Squamous Cell Carcinoma: A Population-Based Analysis. Dis Colon Rectum. 2019 Mar;62(3):302-308.
  • Shaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, Blake Letney, Angela M Schab, Jacqueline A Reilly, Ryan M Sheehy, Jussara Hagen, Nitija Tiwari, Fenghuang Zhan, Mariah R Leidinger, Thomas M O'Dorisio, Joseph Dillon, Ronald A Merrill, David K Meyerholz, Abbey L Perl, Bart J Brown, Terry A Braun, Aaron T Scott, Timothy Ginader, Agshin F Taghiyev, Gideon K Zamba, James R Howe, Stefan Strack, Andrew M Bellizzi, Goutham Narla, Benjamin W Darbro, Frederick W Quelle, Dawn E Quelle. RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth. J Clin Invest. 2019 Mar 4;129(4):1641-1653.
  • Aaron T. Scott, Patrick Breheny, Kendall J. Jeck, Andrew M. Bellizzi, Joseph S. Dillon,
    Thomas M. O’Dorisio, James R. Howe. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. Jan;165(1):166-175.
  • Aaron T. Scott and James R. Howe. Management of Small Bowel Neuroendocrine Tumors. J Oncol Pract. 2018 Aug;14(8):471-482.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
5.0
Show respect for what you say
4.9
Recommend this provider office
4.9
Know important info medical history
4.9
Spend enough time with you
4.9
Rate provider 0-10
03/29/26
Dr Scott is incredible. 10/10 no notes - Verified patient
03/25/26
Professional with a Vocation - Verified patient
03/24/26
Very good at explaining and answering family concern - Verified patient
03/16/26
Dr.Aaron Scott and his staff were amazing. It was my first time seeing him and I was very nervous but, he was able to put my mind at ease and reassure me that my concerns were valid and would be addressed in a timely manner. He made me feel better about my health and the outcomes of my health. He was very professional and compassionate. I would and will see this doctor again and would recommend and trust this doctor to take care of my loved ones as well. The receptionist was very nice and so was the nurse. It was overall a great experience for me. - Verified patient
02/17/26
First visit I think of Hope good experience - Verified patient